Absorption |
Blood-Brain Barrier | BBB+ | 0.9638 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7323 |
P-glycoprotein Substrate | Non-substrate | 0.6428 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9636 |
Non-inhibitor | 0.9518 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8168 |
Distribution |
Subcellular localization | Mitochondria | 0.5456 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6965 |
CYP450 2D6 Substrate | Non-substrate | 0.7007 |
CYP450 3A4 Substrate | Non-substrate | 0.6326 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7806 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9347 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9507 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8263 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9126 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8250 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8736 |
Non-inhibitor | 0.8770 |
AMES Toxicity | Non AMES toxic | 0.8126 |
Carcinogens | Non-carcinogens | 0.9587 |
Fish Toxicity | Low FHMT | 0.5624 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7505 |
Honey Bee Toxicity | High HBT | 0.6411 |
Biodegradation | Not ready biodegradable | 0.8659 |
Acute Oral Toxicity | III | 0.8600 |
Carcinogenicity (Three-class) | Non-required | 0.7385 |